Akorn Inc 

AKRX:NASDAQ

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
16.57 0.38   2.35%0.00%229,019418.4K

Market data is delayed by at least 20 minutes.
As of 01:19 PM ET 8/26/2013
 
 
 

Latest News Headlines for Akorn Inc

Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc.
5 days 53 minutes ago - PR Newswire via Dow Jones News
Editor Note: For more information about this release, please scroll to bottom. LONDON, August 21, 2013 /PRNewswire/ -- The U.S. equity market posted some gains on Tuesday, August 20, 2013. The S&P; 500 ended 0.38% higher at 1,652.35, and the NASDAQ Composite closed the day 0.68% higher at 3,613.59. Shares in healthcare companies ended higher, tracking gains in the broader market. The major movers in the sector included Delcath Systems Inc. (NASDAQ: DCTH), Astex Pharmaceuticals (NASDAQ: ASTX), BioMarin Pharmaceuticals Inc. (NASDAQ: BMRN), and Akorn Inc. (NASDAQ: AKRX). AAAResearchReports.com initiated preliminary technical research on DCTH, ASTX, BMRN, and AKRX. These free reports are accessible by signing today at:
View more recent headlines
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
March 1, 2013
This report contains detailed information about the company's business finances and management.
10-Q
May 10, 2013
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Akorn, Inc. is a manufacturer and markets a full line of diagnostic and therapeutic ophthalmic pharmaceuticals as well as niche hospital drugs and injectable pharmaceuticals. It operates in three segments: ophthalmic, hospital drugs & injectables, and contract services. It operates pharmaceutical manufacturing plants in the United States at Decatur, Illinois and Somerset, New Jersey, and internationally at Paonta Sahib, Himachal Pradesh, India, as well as a central distribution warehouse in Gurnee, Illinois, R&D; centers in Skokie and Vernon Hills, Illinois and corporate offices in Lake Forest, Illinois. It's customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. On February 28, 2012, the Company, through its wholly owned subsidiary, Akorn India Private Limited, acquired selected assets of Kilitch Drugs (India) Limited, and it also acquired selected assets of NBZ Pharma Limited.

Bid/Size
-- / --
Ask/Size
-- / --
Price Open
16.17
Previous Close
16.19
Day High
16.74
Day Low
16.00
52wk High/Date
16.74 / 8/26/2013
52wk Low/Date
11.73 / 11/6/2012
% off 52wk High
-1.02%
% off 52wk Low
41.26%
Beta (5 Yr)
1.0
Market Capitalization
1.6B
Shares Outstanding
96.2M
Volatility Avg
32.00
EPS(TTM)
0.41
P/E Ratio
40.2
Dividend Announcement
--
Dividend Yield
0.00%
Ex-Date
--
Date of Record
--
Payable
0.00 - --
Payable Date
--
Last Trade as of 8/26/2013 1:17 PM ET
 
 
 

AKRX Akorn Inc vs. Peers

Peers 
AKRX
Akorn Inc
21.18%
AKRX
Akorn Inc
0.00%
AKRX
Akorn Inc
2.35%
Compare these stocks